Literature DB >> 9145871

Effect of food intake on pharmacokinetics of oral artemisinin in healthy Vietnamese subjects.

T K Dien1, P J de Vries, N X Khanh, R Koopmans, L N Binh, D D Duc, P A Kager, C J van Boxtel.   

Abstract

The influence of food intake on the pharmacokinetics of artemisinin was studied with six healthy Vietnamese male subjects. In a crossover study, artemisinin capsules (500 mg) were administered with and without food after an overnight fast. Plasma samples were obtained up to 24 h after intake of each drug. Measurement of artemisinin concentrations was performed by high-performance liquid chromatography with electrochemical detection. Tolerance was evaluated according to subjective and objective findings, including repeated physical examinations, routine blood investigations, and electrocardiograms. Pharmacokinetics were analyzed with a noncompartmental method and with a one-compartment model. This model had either zero-order or first-order input. No statistically significant differences were found between the results of the two experimental conditions. Specifically, there were no consistent differences in parameters most likely to be affected by food intake, including absorption profile, absorption rate, bioavailability (f) (as reflected in area under the concentration time curve [AUC]), and drug clearance. Some mean +/- standard deviation parameters after food were as follows: maximum concentration of drug in serum (Cmax), 443 +/- 224 microg x liter(-1); time to Cmax, 1.78 +/- 1.2 h; AUC, 2,092 +/- 1,441 ng x ml(-1) x h, apparent clearance/f, 321 +/- 167 liter x h(-1); mean residence time, 4.42 +/- 1.31 h; and time at which half of the terminal value was reached, 0.97 +/- 0.68 h. The total amount of artemisinin excreted in urine was less than 1% of the dose. We conclude that food intake has no major effect on artemisinin pharmacokinetics. In addition, we conclude tentatively that artemisinin is cleared by the liver, that this clearance does not depend on liver blood flow (i.e., that artemisinin is a so-called low-clearance drug), and that absorption of the drug is not affected by food intake.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145871      PMCID: PMC163852     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

2.  Metabolic fate of Qinghaosu in rats; a new TLC densitometric method for its determination in biological material.

Authors:  X Y Niu; L Y Ho; Z H Ren; Z Y Song
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Jan-Mar       Impact factor: 2.441

3.  Biological determinants of propranolol disposition in man.

Authors:  D M Kornhauser; A J Wood; R E Vestal; G R Wilkinson; R A Branch; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

Review 4.  Metabolism of antimalarial sesquiterpene lactones.

Authors:  I S Lee; C D Hufford
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

5.  In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum.

Authors:  M H Alin; A Björkman; M Ashton
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Sep-Oct       Impact factor: 2.184

6.  Susceptibility of Thai isolates of Plasmodium falciparum to artemisinine (qinghaosu) and artemether.

Authors:  S Thaithong; G H Beale
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

7.  Uptake of [3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro.

Authors:  H M Gu; D C Warhurst; W Peters
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

Review 8.  Qinghaosu (artemisinin): an antimalarial drug from China.

Authors:  D L Klayman
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

9.  Effects of qinghaosu and related compounds on incorporation of [G-3H] hypoxanthine by Plasmodium falciparum in vitro.

Authors:  Z L Li; H M Gu; D C Warhurst; W Peters
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

10.  Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients.

Authors:  M Hassan Alin; M Ashton; C M Kihamia; G J Mtey; A Björkman
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Jan-Feb       Impact factor: 2.184

View more
  19 in total

1.  Establishment of an in vitro screening model for neurodegeneration induced by antimalarial drugs of the artemisinin-type..

Authors:  G Schmuck; R K Haynes
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.

Authors:  Stephanie E Reuter; Allan M Evans; Sepehr Shakib; Yvonne Lungershausen; Barbara Francis; Giovanni Valentini; Antonella Bacchieri; David Ubben; Silvia Pace
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859

3.  A small amount of fat does not affect piperaquine exposure in patients with malaria.

Authors:  Anna Annerberg; Khin Maung Lwin; Niklas Lindegardh; Sakchai Khrutsawadchai; Elizabeth Ashley; Nicholas P J Day; Pratap Singhasivanon; Joel Tarning; Nicholas J White; François Nosten
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

4.  Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin.

Authors:  U S Svensson; M Ashton
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

5.  Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseases.

Authors:  Pamela J Weathers; Patrick R Arsenault; Patrick S Covello; Anthony McMickle; Keat H Teoh; Darwin W Reed
Journal:  Phytochem Rev       Date:  2011-06       Impact factor: 5.374

6.  Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea.

Authors:  Rajeev K Mehlotra; Mark N Ziats; Moses J Bockarie; Peter A Zimmerman
Journal:  Eur J Clin Pharmacol       Date:  2006-02-28       Impact factor: 2.953

7.  In vitro evidence for auto-induction of artemisinin metabolism in the rat.

Authors:  S Gupta; U S Svensson; M Ashton
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jul-Sep       Impact factor: 2.441

8.  Simulated digestion of dried leaves of Artemisia annua consumed as a treatment (pACT) for malaria.

Authors:  Pamela J Weathers; Nikole J Jordan; Praphapan Lasin; Melissa J Towler
Journal:  J Ethnopharmacol       Date:  2013-12-06       Impact factor: 4.360

9.  Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.

Authors:  Kevin T Batty; Sam Salman; Brioni R Moore; John Benjamin; Sook Ting Lee; Madhu Page-Sharp; Nolene Pitus; Kenneth F Ilett; Ivo Mueller; Francis W Hombhanje; Peter Siba; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

10.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.